Mid Day

Govt caps cancer drug trade margins at 30 pc to make treatment more affordable

Under the new measure, margins charged on the supply and sale of non-scheduled anti-cancer drugs will be limited to 30 per cent of their maximum retail price (MRP). These medicines fall outside the list of drugs covered by government-fixed ceiling prices